85 related articles for article (PubMed ID: 8176476)
1. Technetium-99m-labeled monoclonal antibodies: influence of technetium-99m binding sites.
John E; Thakur ML; Wilder S; Alauddin MM; Epstein AL
J Nucl Med; 1994 May; 35(5):876-81. PubMed ID: 8176476
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC
J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-labeled monoclonal antibodies for immunoscintigraphy. Simplified preparation and evaluation.
Thakur ML; DeFulvio JD
J Immunol Methods; 1991 Mar; 137(2):217-24. PubMed ID: 2013698
[TBL] [Abstract][Full Text] [Related]
4. Tumor scintigraphy by the method for subtracting the initial image with technetium-99m labeled antibody.
Karube Y; Katsuno K; Ito S; Matsunaga K; Takata J; Kuroki M; Murakami M; Matsuoka Y
Ann Nucl Med; 1999 Dec; 13(6):407-13. PubMed ID: 10656275
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m labeled monoclonal antibodies: evaluation of reducing agents.
Thakur ML; DeFulvio J; Richard MD; Park CH
Int J Rad Appl Instrum B; 1991; 18(2):227-33. PubMed ID: 2026499
[TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy of human mammary carcinoma xenografts using monoclonal antibodies 12H12 and BM-2 labeled with 99mTc and radioiodine.
Brümmendorf TH; Kaul S; Schuhmacher J; Baum RP; Matys R; Klivényi G; Adams S; Bastert G
Cancer Res; 1994 Aug; 54(15):4162-8. PubMed ID: 8033148
[TBL] [Abstract][Full Text] [Related]
7. Scintigraphic detection of xenografted renal tumor by anti-renal cancer monoclonal antibody radiolabeled with technetium-99m.
Mitsui K; Taki T; Miyagawa Y; Yamada Y; Honda N; Fukatsu H; Yoshikawa K; Segawa A
Hinyokika Kiyo; 1995 Aug; 41(8):593-601. PubMed ID: 7572438
[TBL] [Abstract][Full Text] [Related]
8. Direct technetium-99m labeling of three anticancer monoclonal antibodies: stability, pharmacokinetics and imaging.
Gooden CS; Snook DE; Maraveyas A; Rowlinson-Busza G; Peters AM; Epenetos AA
J Nucl Med; 1995 May; 36(5):842-9. PubMed ID: 7738662
[TBL] [Abstract][Full Text] [Related]
9. Direct labeling of monoclonal antibodies with 99mTc and radioimmunodetection of a murine mammary carcinoma with 99mTc-B2C114.
Duran AP; Asurmendi S; D'Orio E; Horenstein AL; de Castiglia SG
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):33-7. PubMed ID: 7632765
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-labeled monoclonal antibody with preserved immunoreactivity and high in vivo stability.
Arano Y; Yokoyama A; Furukawa T; Horiuchi K; Yahata T; Saji H; Sakahara H; Nakashima T; Koizumi M; Endo K
J Nucl Med; 1987 Jun; 28(6):1027-33. PubMed ID: 3585492
[TBL] [Abstract][Full Text] [Related]
11. Direct labeling of monoclonal antibodies with technetium-99m by photoactivation.
Sykes TR; Woo TK; Baum RP; Qi P; Noujaim AA
J Nucl Med; 1995 Oct; 36(10):1913-22. PubMed ID: 7562064
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies as agents for selective radiolabeling of human neutrophils.
Thakur ML; Richard MD; White FW
J Nucl Med; 1988 Nov; 29(11):1817-25. PubMed ID: 3141596
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preliminary evaluation of a new chelate N2S4 for use in labeling proteins with metallic radionuclides.
Najafi A; Alauddin MM; Siegel ME; Epstein AL
Int J Rad Appl Instrum B; 1991; 18(2):179-85. PubMed ID: 2026493
[TBL] [Abstract][Full Text] [Related]
14. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
15. [Labeling of antihuman bladder carcinoma monoclonal antibody with a technetium-99m and radioimmunoimaging of human bladder carcinoma xenograft in nude mice].
Samten B; Yu L; Zhang C
Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):10-2. PubMed ID: 9275678
[TBL] [Abstract][Full Text] [Related]
16. Preparation and properties of antitumor monoclonal antibodies labeled with metallic radionuclides indium-111, gallium-67, and technetium-99m.
Endo K; Sakahara H; Nakashima T; Koizumi M; Ohta H; Kawamura Y; Kunimatsu M; Furukawa T; Ohmomo Y; Arano Y
NCI Monogr; 1987; (3):135-40. PubMed ID: 3469526
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoscintigraphy of pancreatic cancer in tumor-bearing athymic nude mice using (99m)technetium-labeled anti-KL-6/MUC1 antibody.
Matsumura K; Niki I; Tian H; Takuma M; Hongo N; Matsumoto S; Mori H
Radiat Med; 2008 Apr; 26(3):133-9. PubMed ID: 18683568
[TBL] [Abstract][Full Text] [Related]
18. [Immunoscintigraphy of breast cancer xenografts. 99m-Tc-labeled anti-mucin monoclonal antibodies BM-7 and 12H12].
Brümmendorf TH; Kaul S; Schuhmacher J; Baum RP; Klivény G; Matys R; Eichler A; Gückel B; Beldermann F; Bastert G
Nuklearmedizin; 1995 Oct; 34(5):197-202. PubMed ID: 7479094
[TBL] [Abstract][Full Text] [Related]
19. Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates.
Ultee ME; Bridger GJ; Abrams MJ; Longley CB; Burton CA; Larsen SK; Henson GW; Padmanabhan S; Gaul FE; Schwartz DA
J Nucl Med; 1997 Jan; 38(1):133-8. PubMed ID: 8998167
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
